PaidMDT8 min read
MDT — pipeline value the Street ignores
Device adoption is steepening past the conservative model.
Subscriber note
Read the rest with Owen
Subscribers get the full thesis, the levels, and my positioning on MDT. Subscribe to read on.
Owen Pierce covers devices & large-cap pharma. Every call is captured from live market data — never self-reported.
71%
Win rate
+1.8%
Avg return
7
Closed calls
Verified over a rolling 30-day window. Past performance is not a reliable indicator of future results.
- Every paid note in full — including this one
- Live calls with entries and exits as they happen
- The full verified track record, not just the highlights
- Comments and the subscriber community
Opinion. The author may or may not hold positions discussed. Not advice. Not a financial promotion approved under FSMA s.21. Quote data is delayed. Past performance is not a reliable indicator of future results.